|
Cost-effectiveness of anidulafungin in confirmed candidaemia and other invasive Candida infections in Spain |
Grau S, Salavert M, Carlos Pozo Laderas J, Garcia Vargas M, Barrueta JA, Mir N |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Grau S, Salavert M, Carlos Pozo Laderas J, Garcia Vargas M, Barrueta JA, Mir N. Cost-effectiveness of anidulafungin in confirmed candidaemia and other invasive Candida infections in Spain. Journal de Mycologie Medicale 2013; 23(3): 155-163 Indexing Status Subject indexing assigned by NLM MeSH Antifungal Agents /economics /therapeutic use; Candidemia /drug therapy /economics /epidemiology; Candidiasis, Invasive /drug therapy /economics /epidemiology; Cost-Benefit Analysis; Echinocandins /economics /therapeutic use; Health Care Costs; Humans; Multicenter Studies as Topic /economics /statistics & Randomized Controlled Trials as Topic /economics /statistics & Spain /epidemiology; numerical data; numerical data AccessionNumber 22013031549 Date bibliographic record published 30/08/2013 |
|
|
|